Recent headlines have raised significant questioning regarding Wockhardt’s cough medication, specifically concerning the identification of unacceptable levels of dextromethorphan and certain contaminants. Although the company initially claimed its commitment to safety, several cases of adverse reactions, including severe brain injury and potentia